Saiki Julie
SEC insider (Form 3/4/5 filer). CIK 0002154197. Chief Strategy Officer at ADIAL PHARMACEUTICALS, INC. (ADIL). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in ENCINO, CA.
Companies Saiki Julie has filed insider reports for
- ADIAL PHARMACEUTICALS, INC. (ADIL): Officer, Chief Strategy Officer
Saiki Julie
CIK: 0002154197
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADIL
ADIAL PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions